Ephedrae Herbal Composition for Acute Tracheobronchitis Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for acute tracheobronchitis often rely on antibiotics, which can lead to drug resistance and poor efficacy, especially in cases where antibiotic therapy is not indicated, and there is a need for alternative pharmaceutical compositions that effectively manage symptoms like cough and phlegm retention.
Innovation Solution
A pharmaceutical composition containing EPHEDRAE HERBA, GYPSUM FIBROSUM, FORSYTHIAE FRUCTUS, SCUTELLARIAE RADIX, MORI CORTEX, ARMENIACAE SEMEN AMARUM, PEUCEDANI RADIX, PINELLIAE RHIZOMA, CITRI RETICULATAE PERICARPIUM, FRITILLARIAE THUNBERGII BULBUS, ARCTII FRUCTUS, LONICERAE FLOS, RHEI RADIX ET RHIZOMA, PLATYCODONIS RADIX, and GLYCYRRHIZAE RADIX ET RHIZOMA, which work together to clear phlegm-heat, disperse lung qi, and relieve cough.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antibiotics are used to treat acute tracheobronchitis, then infection control is improved, but drug resistance increases and efficacy decreases
Solution Approach 1:
The patent extracts the core therapeutic function from antibiotic-based treatment and isolates it into a specific herbal composition. By taking out the infection control function from the problematic antibiotic treatment paradigm, the invention creates an alternative that achieves the same therapeutic goal without the harmful side effect of drug resistance
Solution Approach 2:
The herbal composition acts as an intermediary substance that mediates between the patient's immune system and the infection. Instead of using antibiotics that directly kill bacteria (causing resistance), the herbal formulation works through multiple mechanisms including anti-inflammatory effects, immune modulation, and direct antimicrobial properties of natural compounds, thereby controlling infection without selecting for resistant strains
2Ease of operation
If antibiotics are used for acute tracheobronchitis, then symptomatic treatment is provided, but adverse reactions increase
Solution Approach 1:
The patent employs a composite herbal formulation containing multiple ingredients (ephedra, gypsum, forsythia, scutellaria, morus cortex, and other traditional Chinese medicine components) that work synergistically. This composite approach provides comprehensive symptomatic relief through multiple mechanisms while the natural origin of all components ensures a favorable safety profile with minimal adverse reactions
3Object-generated harmful factors
If Traditional Chinese Medicine is used for treatment, then adverse reactions are reduced, but manufacturing precision and standardization become challenging
Solution Approach 1:
The patent specifies precise quantitative parameters for each herbal ingredient in the formulation, transforming the traditional qualitative TCM approach into a standardized quantitative composition. By defining exact amounts or ratios of each component (ephedra, gypsum, forsythia, etc.), the invention maintains the safety advantages of TCM while enabling precise manufacturing and quality control through modern pharmaceutical standards
Data Source
AI summary
A pharmaceutical composition for treating bronchitis and preparation method thereof. Said pharmaceutical composition consists of EPHEDRAE HERBA, GYPSUM FIBROSUM, FORSYTHIAE FRUCTUS, SCUTELLARIAE RADIX, MORI CORTEX, ARMENIACAE SEMEN AMARUM, PEUCEDANI RADIX, PINELLIAE RHIZOMA, etc. Said pharmaceutical composition is useful in relieving cough, eliminating phlegm, relieving asthma and resisting inflammation, so it has good curative effects on the acute tracheobronchitis.